Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: Retrospective findings from a psychiatric emergency service

Alexopoulos, 2004, Expert Consensus Panel for Using Antipsychotics in Older Patients. Using antipsychotic agents in older patients, J Clin Psychiatry, 65, 5 Hamers, 2005, Why do we use physical restraints in the elderly?, Z Gerontol Geriatr, 38, 19, 10.1007/s00391-005-0286-x Currier, 2002, Pharmacological treatment of psychotic agitation, CNS Drugs, 16, 219, 10.2165/00023210-200216040-00002 Brook, 2000, Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis, J Clin Psychiatry, 61, 933, 10.4088/JCP.v61n1208 Weiden, 2002, Best clinical practice with ziprasidone: Update after one year of experience, J Psychiatr Pract, 8, 81, 10.1097/00131746-200203000-00004 Swift, 2002, Validation of the Behavioural Activity Rating Scale (BARS): A novel measure of activity in agitated patients, J Psychiatr Res, 36, 87, 10.1016/S0022-3956(01)00052-8 Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizopbr Bull, 13, 261, 10.1093/schbul/13.2.261 Daniel, 2001, Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: A double-blind, randomized trial, Psychopharmacology (Berl), 155, 128, 10.1007/s002130000658 Wright, 2003, A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy, Clin Ther, 25, 1420, 10.1016/S0149-2918(03)80129-7 Oren, 2005, Intramuscular aripiprazole in acutely agitated psychotic patients Battaglia, 1997, Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study, Am J Emerg Med, 15, 335, 10.1016/S0735-6757(97)90119-4 Schneider, 1990, A meta-analysis of controlled trials of neuroleptic treatment in dementia, J Am Geriatr Soc, 38, 553, 10.1111/j.1532-5415.1990.tb02407.x Casey, 1994, Motor and mental aspects of acute extrapyramidal syndromes, Acta Psychiatr Scand Suppl, 380, 14, 10.1111/j.1600-0447.1994.tb05826.x Lasem, 2001, Intramuscular ziprasidone, 20 mg versus 10 mg, in the short-term management of agitated psychotic patients, J Clin Psychiatry, 62, 12, 10.4088/JCP.v62n0104 Tarsy, 2002, Effects of newer antipsychotics on extrapyramidal function, CNS Drugs, 16, 23, 10.2165/00023210-200216010-00003 Breier, 2002, A double-blind, placebo-controlled dose-response comparison of intra muscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia, Arch Gen Psychiatry, 59, 441, 10.1001/archpsyc.59.5.441 Moran, 2005, Zyprexa IM caution issued in some countries but not U.S., Psychiatric News, 40, 1 Moran, 2005, Zyprexa IM caution issued in some countries but not U.S., Psychiatric News, 40, 66 Rosack, 2005, FDA orders new warning on atypical antipsychotics, Psychiatric News, 40, 1 Preval, 2005, Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study, Gen Hosp Psychiatry, 27, 140, 10.1016/j.genhosppsych.2004.11.004 Guy, 2000, Clinical Global Impressions (CGI), 100 Banazak, 1996, Difficult dementia: Six steps to control problem behaviors, Geriatrics, 51, 36 Fernandez, 2002, Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies, J Clin Psychiatry, 63, 513, 10.4088/JCP.v63n0608 Schneider, 2001, National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer dis ease trial methodology, Am J Geriatr Psychiatry, 9, 346, 10.1097/00019442-200111000-00004 Greco, 2005, A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients, J Clin Psychiatry, 66, 928, 10.4088/JCP.v66n0717 Oechsner, 2005, Parenteral ziprasidone: A new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?, Hum Psychopharmacol, 20, 203, 10.1002/hup.682 Battaglia, 2005, Pharmacological management of acute agitation, Drugs, 65, 1207, 10.2165/00003495-200565090-00003 Glassman, 2001, Antipsychotic drugs: Prolonged QTc interval, torsades de pointes, and sudden death, Am J Psychiatry, 158, 1774, 10.1176/appi.ajp.158.11.1774 Brook, 2000, A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia, Hum Psychopharmacol, 15, 521, 10.1002/1099-1077(200010)15:7<521::AID-HUP235>3.0.CO;2-V Roe, 2003, Concomitant use of antipsychotics and drugs that may prolong the QT interval, J Clin Psychopharmacol, 23, 197, 10.1097/00004714-200304000-00013